← Leaderboards
Kurt I Kamrud
Alphavax Human Vaccines, Inc.
$3,800,000
Attributed
$3,800,000
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2005–08$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
Funding mix
By agency
NIH$3,800,000 · 2
By mechanism
UC1$3,300,000 · 1
U01$500,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Alphavax Human Vaccines, Inc.
Same institution · by research overlap
- Jonathan Smith$21,963,803
- Jeffrey D Chulay$16,245,998
- Robert Olmsted$7,887,006
- Robert A. Olmsted$878,891
- Robert A Olmsted$500,000
Others in their field
Top investigators on “Alphavirus”
- Michael S. Diamond · University Of Pittsburgh At Pittsburgh$35,095,122
- Richard J. Kuhn · Purdue University$33,845,146
- Margaret Kielian · Albert Einstein College Of Medicine$25,371,634
- Jonathan Smith · Alphavax Human Vaccines, Inc.$20,943,892
- Daniel N Streblow · Oregon Health And Science University$20,061,138
- Scott C Weaver · University Of Texas Medical Br Galveston$19,385,767
Research focus
AlphavirusAnimalsAntibodyAntibody FormationAntigensAntigens, ViralAttenuatedBaseBiologicalClinical TrialsClinical Trials, Phase IConditionCyclic GmpCytomegalovirusDosageDoseDrugs, InvestigationalElectroporationEncephalitis Virus, Venezuelan EquineEncephalomyelitis, Venezuelan EquineEquilibriumEvaluationExtracellularAffect